Elevated GlycA and GlycB in combination with decreased SPC2, SPC3 and SPC/Glyc are consistent with the notion that (overweight) people with diabetes present with chronic low‐grade systemic inflammation (Berbudi et al., 2020), given that these markers have previously been associated with inflammation (Lodge et al., 2024). The gene discussed is PCSK2; the disease is diabetes mellitus.